You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 17 results:

Filters: First Letter Of Title is L and Author is Cushman, Mary [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

L

Strotmeyer ES, Arnold AM, Boudreau RM, Ives DG, Cushman M, Robbins JA, Harris TB, Newman AB. Long-term retention of older adults in the Cardiovascular Health Study: implications for studies of the oldest old. J Am Geriatr Soc. 2010 ;58(4):696-701.

Newman AB, Arnold AM, Sachs MC, Ives DG, Cushman M, Strotmeyer ES, Ding J, Kritchevsky SB, Chaves PHM, Fried LP, et al. Long-term function in an older cohort--the cardiovascular health study all stars study. J Am Geriatr Soc. 2009 ;57(3):432-40.

Jenny NS, French B, Arnold AM, Strotmeyer ES, Cushman M, Chaves PHM, Ding J, Fried LP, Kritchevsky SB, Rifkin DE, et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci. 2012 ;67(9):970-6.

Kizer JR, Arnold AM, Jenny NS, Cushman M, Strotmeyer ES, Ives DG, Ding J, Kritchevsky SB, Chaves PHM, Hirsch CH, et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci. 2011 ;66(10):1100-7.

Lutsey PL, Cushman M, Heckbert SR, Tang W, Folsom AR. Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost. 2011 ;106(1):113-20.

Jenny NSwords, Solomon C, Cushman M, Tracy RP, Nelson JJ, Psaty BM, Furberg CD. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study. Atherosclerosis. 2010 ;209(2):528-32.

Olson N, O'Meara ES, Jenny NS, Folsom AR, Bovill EG, Furberg CD, Heckbert SR, Psaty BM, Cushman M. Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults. Am J Hematol. 2008 ;83(7):524-7.

Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC, Koro C. Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. Atherosclerosis. 2014 ;235(2):384-91.

Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010 ;375(9725):1536-44.

Suzuki T, Solomon C, Jenny NSwords, Tracy R, Nelson JJ, Psaty BM, Furberg C, Cushman M. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study. Circ Heart Fail. 2009 ;2(5):429-36.

Garg PK, Arnold AM, Stukovsky KDHinckley, Koro C, Jenny NS, Mukamal KJ, Criqui MH, Furberg CD, Newman AB, Cushman M. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2016 ;36(4):750-6.

Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM, Folsom AR. Lifetime Risk of Venous Thromboembolism in Two Cohort Studies. Am J Med. 2016 ;129(3):339.e19-26.

Harrington LB, Ehlert AN, Thacker EL, Jenny NS, Lopez O, Cushman M, Olson NC, Fitzpatrick A, Mukamal KJ, Jensen MK. Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The Cardiovascular Health Study. Thromb Res. 2024 ;235:148-154.

Häberle AD, Biggs ML, Cushman M, Psaty BM, Newman AB, Shlipak MG, Gottdiener J, Wu C, Gardin JM, Bansal N, et al. Level and change in N-terminal pro B-type Natriuretic Peptide and kidney function and survival to age 90. J Gerontol A Biol Sci Med Sci. 2020 .

Tajuddin SM, Schick UM, Eicher JD, Chami N, Giri A, Brody JA, W Hill D, Kacprowski T, Li J, Lyytikäinen L-P, et al. Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases. Am J Hum Genet. 2016 ;99(1):22-39.

Yamagishi K, Cushman M, Heckbert SR, Tsai MY, Folsom AR. Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol. 2009 ;145(2):221-6.

Appiah D, Heckbert SR, Cushman M, Psaty BM, Folsom AR. Lack of association of plasma gamma prime (γ') fibrinogen with incident cardiovascular disease. Thromb Res. 2016 ;143:50-2.